Company Search:
Advanced Search
Sponsored Links
Reata Pharmaceuticals Inc Company Snapshot
Reata Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reata Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Fulcrum Therapeutics Inc (2020 sales of $8.82 million of which 100% was PHARMACEUTICAL), Sol Gel Technologies Ltd ($8.77 million ), and Ikena Oncology Inc ($9.19 million of which 100% was Biotechnology & Medical Research).

Sales Analysis. During the year ended December of 2020, sales at Reata Pharmaceuticals Inc were $9.02 million. This is a sharp decrease of 66.0% versus 2019, when the company's sales were $26.52 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reata Pharmaceuticals Inc
  Stock Performance Chart for Reata Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/16/2021): 90.87
(Figures in U.S. Dollars)
1 Week 2.8%   13 Weeks -21.4%  
4 Weeks -18.8%   52 Weeks -39.1%  
Reata Pharmaceuticals Inc Key Data:
  Ticker: RETA Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 9,019,000
(Year Ending Jan 2021).
Employees: 273
  Currency: U.S. Dollars Market Cap: 3,285,321,704
  Fiscal Yr Ends: December Shares Outstanding: 36,154,085
  Share Type: COMMON Closely Held Shares: 6,526,717
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.